| Code | Description | Claims | Beneficiaries | Total Paid |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
19,768 |
18,886 |
$320K |
| 80053 |
Comprehensive metabolic panel |
44,376 |
40,256 |
$288K |
| 80061 |
Lipid panel |
30,559 |
29,329 |
$249K |
| 84443 |
Thyroid stimulating hormone (TSH) |
23,817 |
22,655 |
$227K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,229 |
34,666 |
$191K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,068 |
6,780 |
$190K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,062 |
6,768 |
$186K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,489 |
1,270 |
$143K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
22,458 |
21,526 |
$124K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,810 |
2,438 |
$93K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,621 |
3,531 |
$90K |
| 80050 |
General health panel |
4,628 |
4,451 |
$85K |
| 82607 |
|
8,644 |
8,239 |
$73K |
| 84439 |
|
12,585 |
11,974 |
$71K |
| 88142 |
|
4,857 |
4,752 |
$70K |
| 36415 |
Collection of venous blood by venipuncture |
35,616 |
29,308 |
$59K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
10,692 |
9,803 |
$50K |
| 82746 |
|
5,742 |
5,473 |
$46K |
| 87660 |
|
2,786 |
2,665 |
$42K |
| 87480 |
|
2,788 |
2,672 |
$42K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,305 |
2,144 |
$40K |
| 82728 |
|
4,204 |
3,998 |
$34K |
| 87510 |
|
2,571 |
2,466 |
$34K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,818 |
918 |
$33K |
| 85027 |
|
8,999 |
7,401 |
$28K |
| 84153 |
|
2,296 |
2,209 |
$28K |
| 80074 |
|
1,273 |
1,219 |
$25K |
| 87186 |
|
4,783 |
4,439 |
$25K |
| 84403 |
|
1,369 |
1,318 |
$24K |
| 83735 |
|
5,194 |
4,348 |
$21K |
| 84481 |
|
1,789 |
1,727 |
$20K |
| 83540 |
|
4,814 |
4,560 |
$19K |
| 83550 |
|
3,664 |
3,491 |
$19K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,072 |
1,026 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,697 |
3,757 |
$18K |
| 87070 |
|
2,988 |
2,766 |
$17K |
| 81513 |
|
177 |
166 |
$15K |
| 84402 |
|
851 |
819 |
$15K |
| 80076 |
|
2,641 |
1,522 |
$14K |
| 82043 |
|
3,631 |
3,488 |
$13K |
| 87077 |
|
2,419 |
2,232 |
$13K |
| 84702 |
|
1,363 |
1,175 |
$13K |
| 82570 |
|
3,856 |
3,719 |
$12K |
| 83090 |
|
1,329 |
1,294 |
$12K |
| 86038 |
|
1,430 |
1,356 |
$12K |
| 87081 |
|
2,414 |
2,339 |
$12K |
| 83970 |
|
565 |
538 |
$12K |
| 86140 |
|
4,087 |
2,970 |
$11K |
| 87590 |
|
581 |
533 |
$10K |
| 81001 |
|
4,824 |
4,563 |
$9K |
| 86803 |
|
1,062 |
991 |
$9K |
| 84550 |
|
3,004 |
2,845 |
$8K |
| 88108 |
|
367 |
356 |
$8K |
| 85652 |
|
4,702 |
3,724 |
$8K |
| 86780 |
|
914 |
869 |
$8K |
| 87088 |
|
1,756 |
1,642 |
$8K |
| 87205 |
|
2,434 |
2,230 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
205 |
145 |
$6K |
| 87147 |
|
1,547 |
1,443 |
$6K |
| 82565 |
|
1,668 |
687 |
$6K |
| 86769 |
|
156 |
155 |
$6K |
| 84100 |
|
2,118 |
1,546 |
$5K |
| 83690 |
|
1,141 |
1,085 |
$5K |
| 87808 |
|
483 |
433 |
$5K |
| 85610 |
|
2,883 |
1,487 |
$5K |
| 82150 |
|
1,009 |
961 |
$4K |
| 86003 |
|
48 |
43 |
$4K |
| 87340 |
|
741 |
630 |
$4K |
| 86762 |
|
455 |
379 |
$4K |
| 83001 |
|
288 |
285 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
139 |
130 |
$4K |
| 86787 |
|
332 |
278 |
$4K |
| 86430 |
|
881 |
843 |
$4K |
| 85007 |
|
1,890 |
1,480 |
$4K |
| 84146 |
|
239 |
230 |
$3K |
| 88112 |
|
144 |
141 |
$3K |
| 84466 |
|
459 |
438 |
$3K |
| 81003 |
|
2,131 |
2,028 |
$3K |
| 84520 |
|
1,137 |
404 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
102 |
98 |
$3K |
| 83516 |
|
155 |
147 |
$3K |
| 87481 |
|
176 |
165 |
$3K |
| 84480 |
|
273 |
251 |
$3K |
| 83880 |
|
142 |
131 |
$3K |
| 84436 |
|
566 |
526 |
$3K |
| 82248 |
|
720 |
578 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
141 |
129 |
$2K |
| 83721 |
|
808 |
787 |
$2K |
| 83002 |
|
148 |
147 |
$2K |
| 82550 |
|
481 |
396 |
$2K |
| 86592 |
|
561 |
514 |
$2K |
| 83021 |
|
131 |
107 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
38 |
36 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
38 |
36 |
$1K |
| 80164 |
|
153 |
141 |
$1K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
61 |
52 |
$1K |
| 82784 |
|
116 |
108 |
$1K |
| 86709 |
|
166 |
149 |
$1K |
| 86705 |
|
156 |
141 |
$1K |
| 86376 |
|
82 |
79 |
$816.39 |
| 86480 |
|
30 |
27 |
$736.84 |
| 84703 |
|
139 |
101 |
$701.73 |
| 86850 |
|
182 |
143 |
$642.09 |
| 82731 |
|
12 |
12 |
$628.04 |
| 86706 |
|
85 |
82 |
$579.45 |
| 84484 |
|
100 |
86 |
$560.48 |
| 86593 |
|
203 |
148 |
$530.35 |
| 82670 |
|
27 |
27 |
$518.65 |
| 85651 |
|
222 |
164 |
$454.97 |
| 86901 |
|
251 |
203 |
$426.02 |
| 86900 |
|
249 |
203 |
$424.42 |
| 87075 |
|
72 |
63 |
$418.47 |
| 87625 |
|
27 |
26 |
$418.14 |
| 86364 |
|
26 |
25 |
$372.77 |
| 80184 |
|
77 |
56 |
$332.49 |
| 82785 |
|
27 |
26 |
$330.68 |
| 87493 |
|
16 |
15 |
$289.88 |
| 86141 |
|
30 |
30 |
$256.11 |
| 85730 |
|
92 |
88 |
$241.71 |
| 87285 |
|
20 |
18 |
$211.47 |
| 86200 |
|
26 |
25 |
$209.44 |
| 82977 |
|
39 |
38 |
$204.02 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
672 |
650 |
$201.68 |
| 84156 |
|
81 |
76 |
$184.86 |
| 82140 |
|
20 |
12 |
$165.75 |
| 85045 |
|
55 |
51 |
$164.28 |
| 82247 |
|
41 |
25 |
$160.72 |
| 82330 |
|
17 |
12 |
$149.52 |
| 82105 |
|
12 |
12 |
$133.45 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
1,121 |
1,084 |
$127.19 |
| 86735 |
|
13 |
13 |
$126.20 |
| 86765 |
|
12 |
12 |
$113.75 |
| 83020 |
|
14 |
13 |
$112.42 |
| 87335 |
|
13 |
12 |
$107.29 |
| 84478 |
|
29 |
26 |
$103.20 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
114 |
106 |
$94.26 |
| 87045 |
|
13 |
12 |
$84.50 |
| 86431 |
|
14 |
14 |
$76.21 |
| 84132 |
|
31 |
27 |
$76.15 |
| 85018 |
|
58 |
40 |
$48.01 |
| 85014 |
|
37 |
26 |
$33.04 |
| 80051 |
|
40 |
39 |
$26.48 |
| 3046F |
|
254 |
246 |
$0.00 |
| 3051F |
|
460 |
449 |
$0.00 |
| 3044F |
|
3,263 |
3,155 |
$0.00 |
| 3052F |
|
133 |
128 |
$0.00 |